Antimitotic Agents: all 5,052 studies that test it
Page 46 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00058253Phase 1
- Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate CancerCompletedNCT00058084Phase 2
- S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerWithdrawnNCT00057928Phase 3
- T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma PatientsTerminatedNCT00057382Phase 2/3
- Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00055861Phase 2
- S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNCT00055835Phase 2
- Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerCompletedNCT00055770Phase 1/2
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseCompletedNCT00055731Phase 3
- A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid ArthritisCompletedNCT00055133Phase 2
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00054587Phase 3
- Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid TumorsCompletedNCT00054548Phase 1
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
- Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
- BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00054314Phase 2
- T900607 in Treating Patients With Unresectable Liver CancerCompletedNCT00054262Phase 2
- T900607 in Treating Patients With Gastroesophageal Junction CancerCompletedNCT00054249Phase 2
- Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054210Phase 3
- Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
- Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerTerminatedNCT00054184Phase 3
- Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple MyelomaCompletedNCT00054158Phase 2
- S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054054Phase 2
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerTerminatedNCT00053911Phase 3
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00052845Phase 2
- Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative DisordersCompletedNCT00052572Phase 2
- Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00052455Phase 3
- Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial CancerCompletedNCT00052312Phase 2
- Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast CancerCompletedNCT00052169Phase 2
- Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaCompletedNCT00051571Phase 2
- Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate CancerCompletedNCT00050596Phase 2
- EPO906 in Carcinoid and Other Neuroendocrine TumorsCompletedNCT00050349Phase 2
- Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung CancerCompletedNCT00049790Phase 2
- Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerTerminatedNCT00049660Phase 2/3
- S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionCompletedNCT00049400Phase 1
- Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
- Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00049283Phase 1
- Bortezomib and Docetaxel in Treating Patients With Advanced Solid TumorsTerminatedNCT00049088Phase 1
- Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusSuspendedNCT00048529Phase 2
- Iressa/Docetaxel in Non-Small-Cell Lung CancerWithdrawnNCT00048087Phase 2
- This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.CompletedNCT00047840Phase 2
- Study of ABT-751 in Patients With Refractory Hematologic MalignanciesCompletedNCT00047489Phase 1
- Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast CancerCompletedNCT00047255Phase 3
- E7389 in Treating Patients With Advanced Solid TumorsCompletedNCT00047034Phase 1
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone TherapyCompletedNCT00046826Phase 2
- Study of ABI-007 and Taxol in Patients With Metastatic Breast CancerCompletedNCT00046527Phase 3
- ABI-007 in Taxol Resistant Patients With Metastatic Breast CancerCompletedNCT00046514Phase 2
- A Trial of ABI-007 in Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00046423Phase 1
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00045448Phase 1
- Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00045227Phase 2
- Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00045097Phase 2
- Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast CancerCompletedNCT00044993Phase 2
- Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell CarcinomaCompletedNCT00044564Phase 2
- Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer PatientsCompletedNCT00044538Phase 2
- Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer PatientsCompletedNCT00044525Phase 2
- ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing TaxotereStatus unknownNCT00043576Phase 2/3
- Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.TerminatedNCT00043459Phase 2
- Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.Status unknownNCT00043446Phase 2
- Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.Status unknownNCT00043433Phase 2
- Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00042809Phase 1
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042315Phase 3
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042302Phase 3
- Docetaxel in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00041093Phase 2
- Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00040807Phase 2
- Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00040794Phase 2
- Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryStatus unknownNCT00039546Phase 3
- Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00039520Phase 2
- BAY 59-8862 in Treating Patients With Advanced Kidney CancerStatus unknownNCT00039169Phase 2
- BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's LymphomaStatus unknownNCT00039156Phase 2
- Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerStatus unknownNCT00039039Phase 3
- A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00038545Phase 2
- Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaCompletedNCT00038246Phase 1/2
- Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed MalignanciesCompletedNCT00038207Phase 2
- Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate CancerCompletedNCT00038194Phase 1
- Intravenous Estramustine With Taxol in Hormone Refractory Prostate AdenocarcinomaCompletedNCT00038168Phase 1/2
- ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 1
- BMS-247550 in Treating Patients With Stage IV MelanomaCompletedNCT00036764Phase 2
- A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based ChemotherapyCompletedNCT00035516Phase 2
- EPO906 Therapy in Patients With Advanced Kidney CancerCompletedNCT00035243Phase 2
- EPO906 Therapy in Patients With Advanced MelanomaCompletedNCT00035165Phase 2
- Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung CancerCompletedNCT00035152Phase 3
- EPO906 Therapy in Patients With Advanced Breast CancerCompletedNCT00035126Phase 2
- EPO906 Therapy in Patients With Prostate CancerCompletedNCT00035113Phase 2
- EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal CancerCompletedNCT00035100Phase 2
- EPO906 Therapy in Patients With Advanced Colorectal CancerCompletedNCT00035087Phase 2
- Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung CancerCompletedNCT00034541Phase 1/2
- ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00034346Phase 2
- Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal AdenocarcinomaCompletedNCT00034190Phase 2
- Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the UrotheliumCompletedNCT00034177Phase 2
- Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung CancerCompletedNCT00034164Phase 2
- Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian CancerCompletedNCT00034151Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00033696Phase 2
- Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownNCT00033683Phase 2
- Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00033618Phase 2
- Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerCompletedNCT00033553Phase 2
- Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00033410Phase 1
- Ketoconazole Plus Docetaxel to Treat Prostate CancerCompletedNCT00032825Phase 1
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00032032Phase 1
- Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNCT00031954Phase 2
- Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00031876Phase 1/2
- Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00031629Phase 2
- Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaTerminatedNCT00031577Phase 1